Bicalutamide 50մգ N30

Use Bicalutamide is used to treat prostate cancer as part of combination therapy with a gonadotropin-releasing hormone (GnRH) analog or with surgical castration. How to take For advanced prostate cancer in combination with a GnRH analog or surgical castration, the drug is taken orally at 50 mg once a day. Treatment with Bicalutamide should be started simultaneously with the initiation of GnRH analog therapy or surgical castration. For locally advanced prostate cancer, the drug is taken orally at 150 mg once a day. The drug should be taken long-term, for at least 2 years. If signs of disease progression appear, the drug should be discontinued. Contraindications - Hypersensitivity to bicalutamide or other excipients of the drug. - Concomitant use with terfenadine, astemizole, and cisapride. - The drug should not be prescribed to children and women. - Lactose intolerance, lactase deficiency, or glucose-galactose malabsorption.